We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News
Cannabis & Psychedelics News

US House of Representatives Passes a Cannabis Research Bill

The bill is expected to pass through the Senate and land on the president’s desk for his approval.

Read More

In Arkansas, Four Cannabis Companies Are Accused of THC Inflation

Three cannabis cultivation companies and one testing lab are facing a class action lawsuit in Arkansas. The allegation? That all four conspired to defraud medical cannabis patients by inflating cannabis potency testing results.

Read More

AOAC Opens Call For Cannabis Pesticide Testing Methods

Any cannabis lab analyst that has a unique method for identifying and quantifying pesticides in dried cannabis samples has been invited to submit their technique to AOAC International.

Read More

Just One-in-Four CBD Topical Products in the US Are Accurately Labeled, Study Finds

As a result of their findings, the Johns Hopkins Medicine researchers say that improvements need to be made to the regulatory oversight of these products in order to ensure good product quality and prevent unwanted drug effects.

Read More

Green Scientific Labs Adopts LIMS Software

Green Scientific Labs, the multi-state cannabis testing company, has adopted a new laboratory information management system (LIMS) for immediate use across all its labs.

Read More

Senate Democrats Introduce a Cannabis Decriminalization Bill

If passed, the bill that would legislate the removal of the federal ban on cannabis, which could effectively decriminalize the drug across the nation.

Read More

Microdosing Cannabis Extract Shows “Encouraging” Results in Patient with Alzheimer’s Disease

A 75-year-old man with Alzheimer’s disease is successfully managing his symptoms with microdoses of cannabis, according to a new case report published in the Journal of Medical Case Reports.

Read More

First Trial of Transdermal CBD for Adult Epilepsy Reports Mixed Results

To confirm the findings, the researchers say that additional randomized controlled trials on transdermal CBD for adult focal epilepsy are warranted.

Read More

Industry-Friendly Cannabis Regulations in California Are Failing to Take Public Health Risks Seriously, Researchers Argue

A new viewpoint paper published by research scientists and public health experts in California warns that current cannabis regulations are not doing enough to protect public health.

Read More

 
Advertisement